29. Thyberg J, Moskalewski S (1999) Role of microtubules in the organization of the Golgi complex. Exp Cell Res 246: 263–279. 30. Brown WJ, Farquhar MG (1984) The mannose-6-phosphate receptor for lysosomal enzymes is concentrated in cis Golgi cisternae. Cell 36: 295–307. 31. Uyama T, Morishita J, Jin XH, Okamoto Y, Tsuboi K, et al. (2009) The tumor suppressor gene H-Rev107 functions as a novel Ca2+-independent cytosolic phospholipase A1/2 of the thiol hydrolase type. J Lipid Res 50: 685–693. 32. Uyama T, Jin XH, Tsuboi K, Tonai T, Ueda N (2009) Characterization of the human tumor suppressors TIG3 and HRASLS2 as phospholipid-metabolizing enzymes. Biochim Biophys Acta 1791: 1114–1124. 33. Shyu RY, Chang SC, Yu JC, Hsu SJ, Chou JM, et al. (2005) Expression and regulation of retinoid-inducible gene 1 (RIG1) in breast cancer. Anticancer Res 25: 2453–2460. 34. Higuchi E, Chandraratna RA, Hong WK, Lotan R (2003) Induction of TIG3, a putative class II tumor suppressor gene, by retinoic acid in head and neck and lung carcinoma cells and its association with suppression of the transformed phenotype. Oncogene 22: 4627–4635. 35. Lotz K, Kellner T, Heitmann M, Nazarenko I, Noske A, et al. (2005) Suppression of the TIG3 tumor suppressor gene in human ovarian carcinomas is mediated via mitogen-activated kinase-dependent and -independent mecha- nisms. Int J Cancer 116: 894–902. 36. Anantharaman V, Aravind L (2003) Evolutionary history, structural features and biochemical diversity of the NlpC/P60 superfamily of enzymes. Genome Biol 4: R11. 37. Husmann K, Sers C, Fietze E, Mincheva A, Lichter P, et al. (1998) Transcriptional and translational downregulation of H-REV107, a class II tumour suppressor gene located on human chromosome 11q11–12. Oncogene 17: 1305–1312. 38. Hajnal A, Klemenz R, Schafer R (1994) Subtraction cloning of H-rev107, a gene specifically expressed in H-ras resistant fibroblasts. Oncogene 9: 479–490. 39. Jahng WJ, Xue L, Rando RR (2003) Lecithin retinol acyltransferase is a founder member of a novel family of enzymes. Biochemistry 42: 12805–12812. 40. Han BG, Cho JW, Cho YD, Kim SY, Yoon HJ, et al. (2010) Expression, purification and biochemical characterization of the N-terminal regions of human TIG3 and HRASLS3 proteins. Protein Expr Purif 71: 103–107. 41. Huang SL, Shyu RY, Yeh MY, Jiang SY (2002) The retinoid-inducible gene I: effect on apoptosis and mitogen-activated kinase signal pathways. Anticancer Res 22: 799–804. TIG3 Tumor Suppressor 42. Tsai FM, Shyu RY, Lin SC, Wu CC, Jiang SY (2009) Induction of apoptosis by the retinoid inducible growth regulator RIG1 depends on the NC motif in HtTA cervical cancer cells. BMC Cell Biol 10: 15. 43. Pillai S, Bikle DD, Mancianti ML, Cline P, Hincenbergs M (1990) Calcium regulation of growth and differentiation of normal human keratinocytes: modulation of differentiation competence by stages of growth and extracellular calcium. J Cell Physiol 143: 294–302. 44. Simmons DP, Peach ML, Friedman JR, Green MM, Nicklaus MC, et al. (2006) Evidence that sequence homologous region in LRAT-like proteins possesses anti-proliferative activity and DNA binding properties: translational implications and mechanism of action. Carcinogenesis 27: 693–707. 45. Aslan JE, Thomas G (2009) Death by Committee: Organellar Trafficking and Communication in Apoptosis. Traffic 10: 1390–1404. 46. Ouasti S, Matarrese P, Paddon R, Khosravi-Far R, Sorice M, et al. (2007) Death receptor ligation triggers membrane scrambling between Golgi and mitochon- dria. Cell Death Differ 14: 453–461. 47. Matarrese P, Manganelli V, Garofalo T, Tinari A, Gambardella L, et al. (2008) Endosomal compartment contributes to the propagation of CD95/Fas-mediated signals in type II cells. Biochem J 413: 467–478. 48. Degli EM (2008) Organelle intermixing and membrane scrambling in cell death. Methods Enzymol 442: 421–438. 49. Kim R (2005) Recent advances in understanding the cell death pathways activated by anticancer therapy. Cancer 103: 1551–1560. 50. Degli EM, Tour J, Ouasti S, Ivanova S, Matarrese P, et al. (2009) Fas death receptor enhances endocytic membrane traffic converging into the Golgi region. Mol Biol Cell 20: 600–615. 51. Schliwa M, Woehlke G (2003) Molecular motors. Nature 422: 759–765. 52. Sesso A, Fujiwara DT, Jaeger M, Jaeger R, Li TC, et al. (1999) Structural elements common to mitosis and apoptosis. Tissue Cell 31: 357–371. 53. Nozawa K, Fritzler MJ, Takasaki Y, Wood MR, Chan EK (2009) Co-clustering of Golgi complex and other cytoplasmic organelles to crescentic region of half- moon nuclei during apoptosis. Cell Biol Int 33: 148–157. 54. Leist M, Jaattela M (2001) Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev Mol Cell Biol 2: 589–598. 55. Robinson NA, LaCelle PT, Eckert RL (1996) Involucrin is a covalently crosslinked constituent of highly purified epidermal corneocytes: evidence for a common pattern of involucrin crosslinking in vivo and in vitro. J Invest Dermatol 107: 101–107. PLoS ONE | www.plosone.org 9 August 2011 | Volume 6 | Issue 8 | e23230